Passage Bio

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Passage Bio and other ETFs, options, and stocks.

About PASG

Passage Bio, Inc. operates as a genetic medicines company. It focuses on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved treatment options. 

CEO
William Chou
CEOWilliam Chou
Employees
60
Employees60
Headquarters
Philadelphia, Pennsylvania
HeadquartersPhiladelphia, Pennsylvania
Founded
2017
Founded2017
Employees
60
Employees60

PASG Key Statistics

Market cap
18.48M
Market cap18.48M
Price-Earnings ratio
-0.29
Price-Earnings ratio-0.29
Dividend yield
Dividend yield
Average volume
269.40K
Average volume269.40K
High today
$0.3094
High today$0.3094
Low today
$0.2732
Low today$0.2732
Open price
$0.3005
Open price$0.3005
Volume
265.65K
Volume265.65K
52 Week high
$1.39
52 Week high$1.39
52 Week low
$0.257
52 Week low$0.257

People also own

Based on the portfolios of people who own PASG. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.